Descriptor English: | Rivaroxaban |
Descriptor Spanish: | Rivaroxabán |
Descriptor Portuguese: | Rivaroxabana |
Descriptor French: | Rivaroxaban |
Entry term(s): |
5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide BAY 59 7939 BAY 59-7939 BAY 597939 Xarelto |
Tree number(s): |
D02.886.778.727 D03.383.533.640.713 D03.383.903.727 |
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069552 |
Scope note: | A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. |
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
Pharm Action: |
Factor Xa Inhibitors |
Registry Number: | 9NDF7JZ4M3 |
Public MeSH Note: | 2016; RIVAROXABAN was indexed under MORPHOLINES and THIOPHENES 2005-2015 |
History Note: | 2016 (2005) |
DeCS ID: | 55911 |
Unique ID: | D000069552 |
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents |
Date Established: | 2016/01/01 |
Date of Entry: | 2015/07/01 |
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Rivaroxaban
- Preferred
Xarelto
- Narrower
BAY 59-7939
- Narrower
Concept UI |
M0501463 |
Scope note | A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. |
Preferred term | Rivaroxaban |
Entry term(s) |
5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide |
Concept UI |
M0558836 |
Preferred term | Xarelto |
Concept UI |
M0488536 |
Preferred term | BAY 59-7939 |
Entry term(s) |
BAY 59 7939 BAY 597939 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey